Funding
Shorla Oncology raises $35m to accelerate growth
Founded in 2018 by Sharon Cunningham and Orlaith Ryan, Shorla has an advanced pipeline of innovative oncology drugs for rare, orphan and paediatric cancers
Founded in 2018 by Sharon Cunningham and Orlaith Ryan, Shorla has an advanced pipeline of innovative oncology drugs for rare, orphan and paediatric cancers